Skip to main content

Table 4 The distribution of the Structured Interview for the Five-Factor Model of Personality among the studied samples

From: Effect of long-term administration of clonazepam, carbamazepine, and valproate on cognitive, psychological, and personality changes in adult epilepsy: a case–control study

Variables Group 1
N = 35
N (%)
Group 2
N = 18
N (%)
Group 3
N = 31
N (%)
Group 4
N = 15
N (%)
Group 5
N = 40
N (%)
P value
Neuroticism
 Low 8 (22.86%) 0 (0%) 0 (0 %) 3 (20%) 10 (25%) 0.017*
 Intermediate 23 (65.71) 18 (100%) 29 (93.55%) 12 (80%) 28 (70%)  
 High 4 (11.43%) 0 (0%) 2 (6.45%) 0 (0%) 2 (5%)  
Extraversion
 Low 9 (25.7%) 0 (0%) 8 (25.8%) 0 (0%) 6 (15%) 0.002*
 Intermediate 26 (74.3%) 15 (83.3%) 23 (74.2%) 15 (100%) 27 (67.5%)  
 High 0 (0%) 3 (16.7%) 0 (0%) 0 (0%) 7 (17.5%)  
Openness to experience
 Low 26 (74.3%) 9 (50%) 28 (90.3%) 12 (80%) 29 (72.5%) 0.038*
 Intermediate 9 (25.7%) 9 (50%) 3 (9.7%) 3 (20%) 11 (27.5%)  
Agreeableness       
 Low 2 (5.7%) 0 (0%) 1 (3.2%) 0 (0%) 4 (10%) 0.614
 Intermediate 32 (91.4%) 18 (100%) 29 (93.5%) 15 (100%) 36 (90%)  
 High 1 (2.9%) 0 (0%) 1 (3.2%) 0 (0%) 0 (0%)  
Conscientiousness
 Low 10 (28.6%) 0 (0%) 12 (38.7%) 0 (0%) 10 (25%) 0.025*
 Intermediate 24 (68.6%) 18 (100%) 19 (61.3%) 15 (100%) 30 (75%)  
 High 1 (2.9%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)  
  1. Group 1: carbamazepine, group 2: valproate, group 3: carbamazepine and clonazepam, group 4: valproate and clonazepam, group 5: epileptic patients without antiepileptic drugs (AEDs), *significant P value